Not applicableTemporarily pausedNCT06465537
What this trial is testing
CRISPR/Cas9 Instantaneous Gene Editing Therapy to Intraocular Hypertensive POAG With MYOC Mutation
Who this might be right for
Primary Open Angle Glaucoma
Shanghai BDgene Co., Ltd. 9